Authors: Akbar S; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Raza A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar., Mohsin R; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Kanbour A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Qadri S; Irma Lerma Rangel College of Pharmacy, Texas A&M University, Kingsville, TX, United States., Parray A; Neuroscience Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Zar Gul AR; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Philip A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Vijayakumar S; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Merhi M; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar., Hydrose S; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar., Inchakalody VP; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar., Al-Abdulla R; Anatomical Pathology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Abualainin W; Diagnostic Genomic Division, Solid Tumor Section, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Sirriya SA; Diagnostic Genomic Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Al-Bozom I; Anatomical Pathology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Uddin S; Translational Research Institute and Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.; Laboratory Animal Research Center, Qatar University, Doha, Qatar., Khan OM; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Mohamed Ibrahim MI; Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar University, Doha, Qatar., Al Homsi U; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Dermime S; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar.

Source: Frontiers in immunology [Front Immunol] 2023 Jan 18; Vol. 13, pp. 1097117. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

MeSH Terms: Carcinoma, Non-Small-Cell Lung*/diagnosis , Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/diagnosis , Lung Neoplasms*/drug therapy , Immune Checkpoint Inhibitors*/therapeutic use, Humans ; Biomarkers ; Cytokines/blood ; Exosomes ; Immune Checkpoint Proteins/blood

Authors: Pandey P; Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India., Khan F; Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India., Upadhyay TK; Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India., Maqsood R; Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India.

Source: Molecules (Basel, Switzerland) [Molecules] 2023 Jan 15; Vol. 28 (2). Date of Electronic Publication: 2023 Jan 15.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

Authors: Visconti A; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK., Rossi N; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK., Deriš H; Genos Glycoscience Research Laboratory, Zagreb, Croatia., Lee KA; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK., Hanić M; Genos Glycoscience Research Laboratory, Zagreb, Croatia., Trbojević-Akmačić I; Genos Glycoscience Research Laboratory, Zagreb, Croatia., Thomas AM; CIBIO, University of Trento, Trento, Italy., Bolte LA; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands., Björk JR; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands., Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Board R; Department of Oncology, Lancashire Teaching Hospitals NHS Trust, Chorley, UK., Harland M; Division of Haematology and Immunology, Institute of Medical Research at St. James', University of Leeds, Leeds, UK., Newton-Bishop J; Division of Haematology and Immunology, Institute of Medical Research at St. James', University of Leeds, Leeds, UK., Harries M; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Sacco JJ; Liverpool Clatterbridge Cancer Centre, Liverpool, UK.; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Lorigan P; The Christie NHS Foundation Trust, Manchester, UK., Shaw HM; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Weersma RK; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands., Spector TD; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK., Nathan P; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Sasieni P; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Bataille V; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK. bataille@doctors.org.uk.; Department of Dermatology, Mount Vernon Cancer Centre, Northwood, UK. bataille@doctors.org.uk.; Department of Dermatology, West Herts NHS Trust, Herts, UK. bataille@doctors.org.uk., Lauc G; Genos Glycoscience Research Laboratory, Zagreb, Croatia.; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia., Falchi M; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK. mario.falchi@kcl.ac.uk.

Source: BMC cancer [BMC Cancer] 2023 Feb 18; Vol. 23 (1), pp. 166. Date of Electronic Publication: 2023 Feb 18.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Yun KM; Division of Hematology-Oncology, Moores Cancer Center at UC San Diego Health, La Jolla, California., Bazhenova L; Division of Hematology-Oncology, Moores Cancer Center at UC San Diego Health, La Jolla, California.

Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2023 Mar; Vol. 21 (3), pp. 142-149.

Publication Type: Journal Article; Review

Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE

Authors: Thawani R; Knight Cancer Institute, Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR 97239, USA., Agrawal N; Department of Medicine, Oregon Health & Science University, Portland, OR 97239, USA., Taflin NF; Department of Medicine, Oregon Health & Science University, Portland, OR 97239, USA., Kardosh A; Knight Cancer Institute, Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR 97239, USA., Chen EY; Knight Cancer Institute, Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR 97239, USA.

Source: The oncologist [Oncologist] 2023 Jan 18; Vol. 28 (1), pp. 40-47.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Authors: Lin W; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Chen L; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Zhang H; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China., Qiu X; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China., Huang Q; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China., Wan F; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Le Z; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Geng S; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Zhang A; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Qiu S; Department of Radiation Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, 35005, China., Chen L; Department of Neurosurgery & Neurocritical care, Huashan Hospital, Fudan University, Shanghai, China., Kong L; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China. lin.kong@sphic.org.cn.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China. lin.kong@sphic.org.cn.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China. lin.kong@sphic.org.cn., Lu JJ; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China. jiade.lu@sphic.org.cn.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China. jiade.lu@sphic.org.cn.; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China. jiade.lu@sphic.org.cn.

Source: Nature communications [Nat Commun] 2023 Jan 17; Vol. 14 (1), pp. 265. Date of Electronic Publication: 2023 Jan 17.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Li S; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Yu W; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Xie F; Department of Pharmacy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Luo H; Shenzhen Yucebio Technology Co., Ltd., Shenzhen, 518000, Guangdong, China., Liu Z; Department of General Surgery, Zibo Municipal Central Hospital, Binzhou Medical College, Zibo, 255036, Shandong, China., Lv W; Department of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Shi D; Department of Pathology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Yu D; Department of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Gao P; Department of Pathology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Chen C; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Wei M; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Zhou W; Shenzhen Yucebio Technology Co., Ltd., Shenzhen, 518000, Guangdong, China., Wang J; Shenzhen Yucebio Technology Co., Ltd., Shenzhen, 518000, Guangdong, China., Zhao Z; Shenzhen Yucebio Technology Co., Ltd., Shenzhen, 518000, Guangdong, China., Dai X; Department of Medical Oncology, Shandong Provincial Hospital of Traditional Chinese Medicine, Jinan, 250012, China., Xu Q; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Zhang X; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Huang M; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Huang K; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Wang J; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Li J; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Sheng L; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China., Liu L; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. lianliu@sdu.edu.cn.

Source: Nature communications [Nat Commun] 2023 Jan 03; Vol. 14 (1), pp. 8. Date of Electronic Publication: 2023 Jan 03.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Nagasaki J; Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Department of Hematology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan., Ishino T; Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Togashi Y; Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Source: Cancer science [Cancer Sci] 2022 Oct; Vol. 113 (10), pp. 3303-3312. Date of Electronic Publication: 2022 Jul 30.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Authors: Wada S; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan.; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan., Tsunoda T; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.

Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2031699. Date of Electronic Publication: 2022 Jan 25.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

Authors: Kotajima M; Graduate School of Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan., Choi JH; Graduate School of Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Research Institute for Mushroom Science, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan., Kondo M; Graduate School of Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan., D'Alessandro-Gabazza CN; Department of Immunology, Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 524-8507, Japan., Toda M; Department of Immunology, Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 524-8507, Japan., Yasuma T; Department of Immunology, Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 524-8507, Japan., Gabazza EC; Department of Immunology, Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 524-8507, Japan., Miwa Y; Department of Ophthalmology, Keio University School of Medicine, 35 Shina-nomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Shoda C; Department of Ophthalmology, Keio University School of Medicine, 35 Shina-nomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Lee D; Department of Ophthalmology, Keio University School of Medicine, 35 Shina-nomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Nakai A; Department of Ophthalmology, Keio University School of Medicine, 35 Shina-nomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Kurihara T; Department of Ophthalmology, Keio University School of Medicine, 35 Shina-nomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Wu J; Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Research Institute for Mushroom Science, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan., Hirai H; Graduate School of Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Research Institute for Mushroom Science, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan., Kawagishi H; Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.; Research Institute for Mushroom Science, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan.

Source: Molecules (Basel, Switzerland) [Molecules] 2022 Dec 15; Vol. 27 (24). Date of Electronic Publication: 2022 Dec 15.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

Authors: Yu Y; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China., Bai Y; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China.; Department of MR, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China., Zheng P; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China., Wang N; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China., Deng X; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China., Ma H; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China., Yu R; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China., Ma C; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China., Liu P; Department of Radiology, Gansu Provincial Cancer Hospital, Lanzhou, 730050, Gansu, China., Xie Y; Department of Radiology, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China., Wang C; Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China. chenwang@lzu.edu.cn., Chen H; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China. ery_chenh@lzu.edu.cn.

Source: BMC cancer [BMC Cancer] 2022 Nov 30; Vol. 22 (1), pp. 1241. Date of Electronic Publication: 2022 Nov 30.

Publication Type: Randomized Controlled Trial; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Gong X; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China.; Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China., Zhu Y; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China., Zhang Q; Department of Pharmacy, The Affiliated China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China., Qiu X; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China., Lu C; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China., Tong F; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China., Wang Q; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China., Kong W; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China., Zhou H; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China., Liu B; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China., Zhou Y; Department of Respiratory and Critical Care Medicine, The Affiliated China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China., Du J; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China.

Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2143154. Date of Electronic Publication: 2022 Nov 22.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

Authors: Yoshikawa Y; Department of Gastroenterology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan., Imamura M; Department of Gastroenterology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. mimamura@hiroshima-u.ac.jp.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan. mimamura@hiroshima-u.ac.jp., Yamauchi M; Department of Gastroenterology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan., Hayes CN; Department of Gastroenterology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan., Aikata H; Department of Gastroenterology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan., Okamoto W; Cancer Treatment Center, Hiroshima University Hospital, Hiroshima, Japan., Miyata Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Okada M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Hattori N; Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Sugiyama K; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan., Yoshioka Y; Department of Molecular Oral Medicine and Maxillofacial Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan., Toratani S; Department of Molecular Oral Medicine and Maxillofacial Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan., Takechi M; Department of Oral and Maxillofacial Surgery, Program of Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Ueda T; Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Takeno S; Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Kobayashi T; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan., Ohdan H; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan., Teishima J; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Hide M; Department of Dermatology, Graduate School of Biomedical and Sciences, Hiroshima University, Hiroshima, Japan., Nagata Y; Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan., Kudo Y; Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan., Iida K; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Chayama K; Department of Gastroenterology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.; Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.; Hiroshima Institute of Life Sciences, Hiroshima, Japan.

Source: BMC cancer [BMC Cancer] 2022 Nov 29; Vol. 22 (1), pp. 1232. Date of Electronic Publication: 2022 Nov 29.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Zhou Y; Department of Cardiothoracic Surgery, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China., Tan Y; The Medical Department, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, Jiangsu Simcere Diagnostics Co., Ltd, Building 5, No. 699-18 Xuanwu Avenue, Xuanwu District, Nanjing, Jiangsu, China., Zhang Q; The Medical Department, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, Jiangsu Simcere Diagnostics Co., Ltd, Building 5, No. 699-18 Xuanwu Avenue, Xuanwu District, Nanjing, Jiangsu, China., Duan Q; The Medical Department, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, Jiangsu Simcere Diagnostics Co., Ltd, Building 5, No. 699-18 Xuanwu Avenue, Xuanwu District, Nanjing, Jiangsu, China., Chen J; The 1st Dept of Thoracic Medical Oncology, The Second Hospital Of Dalian Medical University, No. 467, Zhongshan Road, Shahekou District, Dalian, 116027, Liaoning, China. chenjundoc2022@163.com.

Source: European journal of medical research [Eur J Med Res] 2022 Oct 29; Vol. 27 (1), pp. 225. Date of Electronic Publication: 2022 Oct 29.

Publication Type: Letter

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 9517857 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-783X (Electronic) Linking ISSN: 09492321 NLM ISO Abbreviation: Eur J Med Res Subsets: MEDLINE

Authors: Emaldi M; Biomarkers in Cancer Unit, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain., Nunes-Xavier CE; Biomarkers in Cancer Unit, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0310 Oslo, Norway.

Source: Cells [Cells] 2022 Apr 25; Vol. 11 (9). Date of Electronic Publication: 2022 Apr 25.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

MeSH Terms: Immune Checkpoint Proteins* , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/genetics, Biomarkers, Tumor/genetics ; Humans ; Immune Checkpoint Inhibitors ; Immunotherapy

Authors: Shiravand Y; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80138 Naples, Italy., Khodadadi F; Faculty of Pharmaceutical Sciences, PES College of Pharmacy, PES University, Bengaluru 560085, India., Kashani SMA; Student Research Committee, Shiraz University of Medical Sciences, Shiraz 7134814336, Iran., Hosseini-Fard SR; Department of Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran 1417613151, Iran., Hosseini S; Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj 6617713446, Iran., Sadeghirad H; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4102, Australia., Ladwa R; Princess Alexandra Hospital, Brisbane, QLD 4102, Australia., O'Byrne K; Princess Alexandra Hospital, Brisbane, QLD 4102, Australia., Kulasinghe A; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4102, Australia.

Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Apr 24; Vol. 29 (5), pp. 3044-3060. Date of Electronic Publication: 2022 Apr 24.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

MeSH Terms: Immune Checkpoint Inhibitors* , Lung Neoplasms*/drug therapy, Humans ; Immune Checkpoint Proteins ; Immunotherapy ; Programmed Cell Death 1 Receptor

Authors: Chen B; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., Zhao H; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., Huang J; Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China., Lv H; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., Xu W; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., Nie C; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., Wang J; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., Zhao J; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., He Y; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., Wang S; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China., Chen X; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China. zlyychenxb0807@zzu.edu.cn.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China. zlyychenxb0807@zzu.edu.cn.

Source: BMC geriatrics [BMC Geriatr] 2022 Dec 21; Vol. 22 (1), pp. 987. Date of Electronic Publication: 2022 Dec 21.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968548 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2318 (Electronic) Linking ISSN: 14712318 NLM ISO Abbreviation: BMC Geriatr Subsets: MEDLINE

Authors: Park BC; Vanderbilt University School of Medicine, Nashville, TN, USA., Jung S; Vanderbilt University School of Medicine, Nashville, TN, USA., Wright JJ; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Source: The oncologist [Oncologist] 2022 Dec 09; Vol. 27 (12), pp. e967-e969.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Authors: Mi Z; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China., Zhang Y; Xiangya School of Medicine, Central South University, Changsha, China., Feng Z; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China., Liu J; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China., Wu J; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China., Tan H; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China., Ma X; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China., Liu Z; Department of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, China., Rong P; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Biological Nanotechnology of National Health Commission, Central South University, Changsha, China.

Source: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2022 Dec; Vol. 50 (1), pp. 301-309.

Publication Type: Journal Article; Meta-Analysis

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101594777 Publication Model: Print Cited Medium: Internet ISSN: 2169-141X (Electronic) Linking ISSN: 21691401 NLM ISO Abbreviation: Artif Cells Nanomed Biotechnol Subsets: MEDLINE

Authors: Martinez-Mugica Barbosa C; Cristina Martinez-Mugica Barbosa, Pharmacy Department, Cabueñes Hospital, Los Prados, Gijon, Spain. cmartinezmugica@gmail.com., Cercós Lletí AC, Pampín Sánchez R, Durán Román C, Terroba Alonso P, Fernández González B

Source: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2022 Dec; Vol. 35 (6), pp. 551-558.

Publication Type: Observational Study; Journal Article

Journal Info: Publisher: Sociedad Española de Quimioterapia Country of Publication: Spain NLM ID: 9108821 Publication Model: Print Cited Medium: Internet ISSN: 1988-9518 (Electronic) Linking ISSN: 02143429 NLM ISO Abbreviation: Rev Esp Quimioter Subsets: MEDLINE